Similarly, a recent study showed that SLC22A3 expression in renal cell carcinoma cell lines also enhanced sensitivity to chemotherapeutics such as melphalan, irinotecan, and vincristine [27]. The gene discussed is SLC22A3; the disease is renal cell carcinoma.